Trending Stock News

Lathrop Investment Management Increased Cvs Health (CVS) Stake By $479,446; Aristotle Capital Management Boosted Ecolab (ECL) Position

CVS Health Corporation (NYSE:CVS) Logo

Lathrop Investment Management Corp increased Cvs Health Corp (CVS) stake by 5.13% reported in 2018Q1 SEC filing. Lathrop Investment Management Corp acquired 7,733 shares as Cvs Health Corp (CVS)’s stock declined 3.22%. The Lathrop Investment Management Corp holds 158,519 shares with $9.86 million value, up from 150,786 last quarter. Cvs Health Corp now has $72.76B valuation. The stock decreased 0.04% or $0.03 during the last trading session, reaching $71.57. About 2.52M shares traded. CVS Health Corporation (NYSE:CVS) has declined 13.06% since June 21, 2017 and is downtrending. It has underperformed by 25.63% the S&P500. Some Historical CVS News: 13/04/2018 – CVS MinuteClinics hires a new chief medical officer in the midst of buying Aetna; 11/04/2018 – CVS rolls out new tool to combat rising drug prices; 05/03/2018 Asia’s Largest Vending Show CVS and the Official Satellite Show of EuroShop Debut ‘World of Retail’ Exhibition; 22/05/2018 – Thousands of Patients’ HIV-Positive Status Revealed by CVS – Class Action Lawsuit Filed; 07/03/2018 – CVS Health Awarded Pharmacy Benefit Management Institute Excellence Award for ScriptPathâ„¢ Prescription Schedule; 16/03/2018 – CVS Health is now offering GlaxoSmithKline’s shingles vaccine, Shingrix, at stores nationwide; 20/03/2018 – CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business; 09/04/2018 – TABLE-CVS Bay 2687.T -2017/18 parent forecast; 28/03/2018 – FDA HEAD GOTTLIEB SAYS CONSOLIDATION OF PHARMACY BENEFIT MANAGERS OPENS DOOR TO MORE “GAMES” BY PHARMA TO BLOCK GENERICS; 06/03/2018 – S&PGR: CVS Health Issuing Senior Unsecured Notes to Partly Fund Aetna Purchase

Aristotle Capital Management Llc increased Ecolab Inc (ECL) stake by 1925.14% reported in 2018Q1 SEC filing. Aristotle Capital Management Llc acquired 324,175 shares as Ecolab Inc (ECL)’s stock rose 9.64%. The Aristotle Capital Management Llc holds 341,014 shares with $46.74M value, up from 16,839 last quarter. Ecolab Inc now has $41.10B valuation. The stock decreased 0.83% or $1.19 during the last trading session, reaching $142.46. About 190,422 shares traded. Ecolab Inc. (NYSE:ECL) has risen 11.05% since June 21, 2017 and is uptrending. It has underperformed by 1.52% the S&P500. Some Historical ECL News: 08/05/2018 – Ecolab Schedules Webcast of Industry Conference for May 15, 2018; 01/05/2018 – ECOLAB 1Q ADJ EPS 91C, EST. 90C; 09/03/2018 – ECOLAB TOP HOLDER CASCADE BOOSTED STAKE TO 11.6%; 01/05/2018 – Ecolab Sees FY Adj EPS $5.30-Adj EPS $5.50; 18/04/2018 – Ecolab Reclassifies Certain Costs From SG&A Expenses to Cost of Sales; 01/05/2018 – Ecolab Raised Full Yr 2018 Adjusted Diluted EPS Forecast to $5.30 to $5.50 +13%-18%; 18/04/2018 – Ecolab Revises 2017 EPS to $5.12 From $5.13; 07/03/2018 – Ecolab Sells China Industrial Phosphonate Chemical Component Business; 17/04/2018 – Republican Tim Pawlenty brings on former Ecolab executive James Seifert to be his gubernatorial campaign chairman; 09/05/2018 – Ecolab Expanding Greensboro Campus to Include Life Sciences Cleanroom Manufacturing Facility

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. The company was upgraded on Thursday, January 4 by Raymond James. Robert W. Baird maintained the stock with “Hold” rating in Thursday, January 4 report. RBC Capital Markets maintained CVS Health Corporation (NYSE:CVS) on Wednesday, August 5 with “Outperform” rating. The firm earned “Outperform” rating on Tuesday, November 7 by Leerink Swann. The firm earned “Outperform” rating on Friday, January 22 by Robert W. Baird. Needham upgraded CVS Health Corporation (NYSE:CVS) on Tuesday, January 30 to “Buy” rating. The rating was maintained by Citigroup on Monday, November 13 with “Neutral”. The firm has “Buy” rating given on Tuesday, December 26 by Tigress Financial. The firm has “Buy” rating given on Monday, December 4 by RBC Capital Markets. Needham maintained CVS Health Corporation (NYSE:CVS) on Tuesday, January 2 with “Buy” rating.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: which released: “CVS And Aetna Are Changing The Healthcare Paradigm” on June 18, 2018, also with their article: “Why CVS Health, Foundation Medicine, and Solid Biosciences Jumped Today” published on June 19, 2018, published: “CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Arizona to Help Combat Opioid Abuse” on June 20, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: and their article: “5 Reasons Disney And Comcast Will Likely Crush The Market In The Future No Matter Who Buys Fox” published on June 20, 2018 as well as‘s news article titled: “AMA Comes Out Against CVS Health (CVS)/Aetna (AET) Merger” with publication date: June 19, 2018.

Since February 16, 2018, it had 2 insider buys, and 1 sale for $713,454 activity. Shares for $619,900 were bought by BROWN C DAVID II on Friday, May 4. DORMAN DAVID W bought 24,300 shares worth $1.51 million. The insider Foulkes Helena sold 19,965 shares worth $1.42 million.

Investors sentiment increased to 0.9 in Q1 2018. Its up 0.18, from 0.72 in 2017Q4. It increased, as 97 investors sold CVS shares while 512 reduced holdings. 117 funds opened positions while 431 raised stakes. 821.03 million shares or 0.67% more from 815.59 million shares in 2017Q4 were reported. Notis reported 51,491 shares. Parthenon Ltd Co reported 2.56% in CVS Health Corporation (NYSE:CVS). Bancorp Of Mellon reported 0.19% in CVS Health Corporation (NYSE:CVS). Moreover, Putnam Investments Limited Com has 0.04% invested in CVS Health Corporation (NYSE:CVS) for 288,311 shares. Wade G W And holds 1.29% of its portfolio in CVS Health Corporation (NYSE:CVS) for 179,118 shares. Peak6 Limited Partnership reported 216,411 shares. Farr Miller Washington Limited Liability Company Dc holds 2.51% or 433,114 shares. Impax Asset Management Ltd Llc stated it has 0.04% in CVS Health Corporation (NYSE:CVS). Sabal Trust Co accumulated 4,924 shares. Columbia Asset owns 7,696 shares. 297,610 are held by Lpl Financial Limited Company. Somerville Kurt F holds 2.46% in CVS Health Corporation (NYSE:CVS) or 179,202 shares. Cubic Asset Mgmt Ltd Liability Corporation reported 81,660 shares. Susquehanna Intl Group Limited Liability Partnership stated it has 1.31M shares or 0.03% of all its holdings. Jefferies Group Ltd Liability Corporation holds 0.04% or 122,408 shares.

Since March 7, 2018, it had 4 insider buys, and 2 selling transactions for $294.14 million activity. Inchaustegui Roberto had sold 4,800 shares worth $659,683 on Wednesday, March 14. $67.25M worth of Ecolab Inc. (NYSE:ECL) was bought by GATES WILLIAM H III. Shares for $860,301 were bought by ETTINGER JEFFREY M.

Investors sentiment decreased to 0.97 in 2018 Q1. Its down 0.05, from 1.02 in 2017Q4. It dropped, as 45 investors sold ECL shares while 298 reduced holdings. 68 funds opened positions while 264 raised stakes. 211.10 million shares or 1.90% less from 215.19 million shares in 2017Q4 were reported. Mitsubishi Ufj Trust And Bk Corp has 534,759 shares. 3,087 were reported by Virtu Fin Ltd Liability Co. 1,475 were reported by Prelude Capital Llc. Telemus Capital Lc holds 0.03% or 3,028 shares in its portfolio. 307 are owned by Destination Wealth Mngmt. Community Financial Bank Na owns 1,041 shares. Guggenheim Lc owns 353,567 shares. Los Angeles Cap Mgmt And Equity Research reported 0% of its portfolio in Ecolab Inc. (NYSE:ECL). Alpha Windward Ltd holds 0% or 29 shares in its portfolio. Advantus Cap Mgmt stated it has 0.09% of its portfolio in Ecolab Inc. (NYSE:ECL). 10,643 are held by Dearborn Prtn Ltd Liability Com. White Pine Capital Limited Liability Com holds 0.59% of its portfolio in Ecolab Inc. (NYSE:ECL) for 11,537 shares. Parametric Portfolio Assoc Ltd Liability Corp reported 939,976 shares. Reliance Tru Of Delaware owns 8,330 shares or 0.18% of their US portfolio. 513 were accumulated by Shine Inv Advisory Ser.

Aristotle Capital Management Llc decreased Ishares Tr (IWD) stake by 135,496 shares to 64,548 valued at $7.74M in 2018Q1. It also reduced Aristotle/Saul Global Opportunities Fund stake by 250,789 shares and now owns 221,332 shares. Spdr S&P 500 Etf Tr (SPY) was reduced too.

Among 23 analysts covering Ecolab (NYSE:ECL), 10 have Buy rating, 1 Sell and 12 Hold. Therefore 43% are positive. Ecolab has $215.0 highest and $93 lowest target. $147.37’s average target is 3.45% above currents $142.46 stock price. Ecolab had 72 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was downgraded by JP Morgan to “Neutral” on Wednesday, May 2. Stifel Nicolaus maintained Ecolab Inc. (NYSE:ECL) on Tuesday, October 31 with “Hold” rating. The firm has “Buy” rating by RBC Capital Markets given on Thursday, January 18. The rating was maintained by Robert W. Baird with “Hold” on Tuesday, October 31. The firm has “Buy” rating by Canaccord Genuity given on Wednesday, February 24. The firm has “Hold” rating given on Friday, January 5 by Citigroup. Deutsche Bank maintained Ecolab Inc. (NYSE:ECL) rating on Wednesday, February 24. Deutsche Bank has “Hold” rating and $110 target. The rating was maintained by Canaccord Genuity with “Buy” on Wednesday, October 11. The firm has “Buy” rating by Oppenheimer given on Tuesday, August 1. The stock has “Hold” rating by Stifel Nicolaus on Wednesday, August 2.

Another recent and important Ecolab Inc. (NYSE:ECL) news was published by which published an article titled: “Honeywell, Dover among companies exiting Iran presence before sanctions” on June 05, 2018.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *